bioRxiv Science⌕ Search

Biology subjects

Vuerich, R.

Publications and source records attributed to Vuerich, R..

2 recordsLinked to original sources

Pericyte contact alters endothelial cell metabolism by promoting exchange of lactate through SLC16A3

Intimate crosstalk between endothelial cells and pericytes is fundamental for vascular development and stability, but the metabolic dimension of this interaction remains poorly defined. Using a filter-based co-culture system that mimics the shared basement membrane of the microcirculation, we performed an integrated multi-omics analysis to investigate how direct contact reprograms both cell types. We found that initial contact does not induce immediate quiescence but rather triggers a transient, low-level activation of an endothelial-to-mesenchymal transition (EndMT)-like state in endothelial cells, characterized by specific upregulation of genes involved in extracellular matrix production (e.g., collagen isoforms) and PDGFR signaling, without a full loss of endothelial identity. Concomitantly, pericytes shifted endothelial cell metabolism, increasing glycolysis and elevating intracellular pyruvate and lactate. Proteomic analysis of the contact interface revealed enrichment of solute carriers, most notably the lactate transporter SLC16A3. Functional studies demonstrated that pericytes act as a glycolytic partner, actively shuttling lactate to endothelial cells via SLC16A3. This lactate did not fuel the TCA cycle but instead served as a signaling metabolite, driving widespread alterations in the endothelial acetylome and lactylome, particularly affecting proteins involved in glycolytic metabolism. In vitro, exogenous lactate potentiated cytokine-induced EndMT and upregulated lactylation-associated genes. The physiological relevance of this lactate shuttle was confirmed in vivo, where endothelial-specific deletion of Slc16a3 in mice impaired postnatal retinal angiogenesis, leading to reduced vessel density and diminished endothelial-pericyte overlap without affecting endothelial cell proliferation. Our findings establish that vessel maturation is orchestrated by a metabolically gated phase of plasticity initiated upon first contact, wherein a targeted EndMT-like program and a pericyte-driven lactate signaling axis are integrated to coordinate vascular network assembly.

physiology↗

SMOC1 Regulates Endothelial-to-Mesenchymal Transition During Cardiac Repair After Myocardial Infarction

Endothelial-to-mesenchymal transition (EndMT) is a crucial, dual-phase process in cardiac repair after myocardial infarction (MI), driving both initial scar stabilization and subsequent pathological fibrosis. Therapeutic targeting requires precise temporal control rather than complete inhibition. This study identifies the matricellular protein SPARC-related modular calcium-binding protein 1 (SMOC1) as a novel regulator of EndMT. Analysis of single-cell RNA sequencing data from post-MI mouse hearts revealed that SMOC1 is highly enriched in a subpopulation of endothelial cells undergoing late EndMT. In vitro, SMOC1 expression was upregulated during cytokine-induced EndMT in human endothelial cells. Its siRNA-mediated knockdown exacerbated the EndMT phenotype, increasing mesenchymal marker expression and cell morphology changes, effects rescued by recombinant SMOC1 (rSMOC1). Mechanistically, SMOC1 deficiency enhanced TGF-{beta}2-induced SMAD2 phosphorylation, while rSMOC1 attenuated this pathway and promoted a shift from the short to the long, signaling-competent isoform of endoglin. In vivo, endothelial-specific SMOC1 deficiency (SMOC1{Delta}EC) in mice promoted age-associated EndMT and profoundly worsened post-MI outcomes. After MI, SMOC1{Delta}EC mice exhibited exacerbated cardiac dysfunction, ventricular dilation, pathological fibrosis, increased inflammatory cell infiltration, reduced survival, and a higher incidence of cardiac rupture compared to controls. Collectively, these findings establish SMOC1 as a critical endogenous modulator of EndMT that restrains its pathological progression. SMOC1 coordinates endothelial cell phenotype, in part by fine-tuning TGF-{beta}/endoglin signaling, and its loss accelerates maladaptive remodeling post-MI. Thus, SMOC1 represents a potential therapeutic target for spatially and temporally controlling EndMT to improve cardiac repair

pathology↗